Targeted Radiopharmaceuticals Summit Conference Targeted Radiopharmaceuticals Summit CertaraJuly 11, 2024
A literature review of drug transport mechanisms during lactation Publication A literature review of drug transport mechanisms during lactation The literature review titled "A literature review of drug transport mechanisms during lactation," authored by…CertaraJuly 7, 2024
Technologies for the analysis and utilization of vast amounts of data in drug discovery research [Japan Webinar] On-Demand Webinar Technologies for the analysis and utilization of vast amounts of data in drug discovery research [Japan Webinar] This webinar will be held in Japanese only. Certara introduced D360, a drug discovery research…CertaraJuly 3, 2024
University of Florida Wins 2023/24 Certara-Simcyp™ Grant and Partnership Scheme Announcement University of Florida Wins 2023/24 Certara-Simcyp™ Grant and Partnership Scheme RADNOR, PA — July 3, 2024 - Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraJuly 3, 2024
Phoenix UGM Europe 2024 Live Events Phoenix UGM Europe 2024 Join the worldwide Phoenix user community and the Certara Phoenix team to learn how our…CertaraJune 28, 2024
Categorizing & Managing Risks in Aggregate Safety Reports Blog Categorizing & Managing Risks in Aggregate Safety Reports Categorizing Risks From a sponsor’s first authorization to conduct a clinical drug trial in any…CertaraJune 28, 2024
How AI-powered writing software can bring a benefit in Japan [Japan Webinar] On-Demand Webinar How AI-powered writing software can bring a benefit in Japan [Japan Webinar] This webinar will be held in Japanese only. Medical writing is a critical part of…CertaraJune 27, 2024
Catalyzing DMTA Information into Insights On-Demand Webinar Catalyzing DMTA Information into Insights Drug discovery is a data-driven research process that requires accurate data capture, ample and reliable…CertaraJune 27, 2024
Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain Publication Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain CertaraJune 26, 2024
Adopting the Power of AI to Drug Development Projects: Making go/no-go decisions with MBMA and CODEx Clinical Outcome database Press Coverage Adopting the Power of AI to Drug Development Projects: Making go/no-go decisions with MBMA and CODEx Clinical Outcome database CertaraJune 26, 2024